English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 849937 Online Users : 682
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
免疫醫學研究中心
林文傑
--會議論文/會議摘要
--期刊論文
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
免疫醫學研究中心
>
林文傑
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
林文傑(Wen-Jye Lin)
ORCID:0000-0001-8821-9813
Loading...
Collection
會議論文/會議摘要
[
1
/2]
期刊論文
[
18
/18]
Siblings
朱清良(2005-2010)
[
13
/14]
林素珍(2008-2009)
[
2
/2]
莊宗顯
[
85
/87]
莊懷佳
[
50
/54]
蘇郁文
[
23
/23]
謝世良
[
6
/6]
譚澤華
[
70
/76]
高承源
[
25
/27]
黃慶裕
[
10
/11]
其他
[
7
/8]
Community Statistics
近3年內發表的文件:4(20.00%)
含全文筆數:19(95.00%)
文件下載次數統計
下載大於0次:19(100.00%)
下載大於100次:17(89.47%)
檔案下載總次數:7471(0.14%)
最後更新時間: 2024-11-28 13:45
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
PTEN acts as a crucial inflammatory...
DUSP22 inhibits lung tumorigenesis ...
Suppression of androgen receptor si...
Single-cell RNA sequencing uncovers...
Ultra-small platinum nanoparticle-e...
Prognostic significance of o-glcnac...
Molecular mechanisms of dual-specif...
DUSP22 suppresses prostate cancer p...
PP4 deficiency leads to DNA replica...
Subnanometer gold clusters adhere t...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-10 of 20. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-07-19
PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells
iScience. 2024 Jul 19;27(7):Article number 110388.
2024-06-14
DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling
Cell Death Discovery. 2024 Jun 14;10:Article number 285.
2023-04
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis
Cancer Science. 2023 Apr;114(4):1479-1490.
2022-02-18
Single-cell RNA sequencing uncovers the individual alteration of intestinal mucosal immunocytes in Dusp6 knockout mice
iScience. 2022 Feb 18;25(2):Article number 103738.
2021-08-16
Ultra-small platinum nanoparticle-enabled catalysis and corrosion susceptibility reverse tumor hypoxia for cancer chemoimmunotherapy
ACS Applied Bio Materials. 2021 Aug 16;4(8):6527-6538.
2021-08-12
Prognostic significance of o-glcnac and PKM2 in hormone receptor-positive and HER2-nonenriched breast cancer
Diagnostics. 2021 Aug 12;11(8):Article number 1460.
2019-12
DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis
FASEB Journal. 2019 Dec 5;33(12):14653-14667.
2019-07
PP4 deficiency leads to DNA replication stress that impairs immunoglobulin class switch efficiency
Cell Death and Differentiation. 2019 Jul;26 (7):1221-1234.
2019-02
Molecular mechanisms of dual-specificity phosphatase 22 (DUSP22) in suppression of tumorigenesis: The potential involvement of the EGFR/PD-L1 axis
Cancer Immunology Research. 2019 Feb;7(2):B172.
2019-01
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer clls
Cancer Science. 2019 Jan;110(1):279-288.
Showing items 1-10 of 20. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback